Luis Oliverio Ambriz Garcia: Key Points From the ASH 2026 Guidelines on Iron Deficiency
Luis Oliverio Ambriz Garcia, Doctor, Specialist in Internal Medicine at HRAEB, Chief Executive Officer of Memodi, shared a post on X about a recent article by Jacquelyn M. Powers et al., published in Blood Advances, adding:
“Latest ASH guidelines (2026) on iron deficiency.
Key points:
- Adult: ferritin 30 ng/mL or less, deficiency. Sensitivity 67%, specificity 96%. The threshold applies even without anemia; the diagnosis does not depend on hemoglobin.
- With symptoms or persistent risk factor, the cutoff rises to 50 ng/mL or less. The cost is more false positives, so it’s best to use it in those with a real pretest probability.
- Inflammation: ferritin plus TSAT, never ferritin alone. Applies in heart failure, CKD, IBD, cancer, and rheumatic disease. Diagnosis is considered with TSAT less than 20% or ferritin less than 100 ng/mL. TSAT should be taken after fasting for 5 to 9 hours and without iron supplements.
- The lab’s ‘normal range’ is a problem. The lower limits for ferritin were set with a ‘seemingly healthy’ population that included people with deficiency. A ferritin of 18 marked as ‘normal’ on the report is still deficiency.
I’m going to finish reading them thoroughly to update the apps.”
Title: American Society of Hematology 2026 guidelines for diagnosis of iron deficiency
Authors: Jacquelyn M Powers, Ming Yeong Lim, Maureen O. Achebe, Imo J Akpan, Michael Auerbach, Megan C Brown, Maria Paula Cardenas, Caroline Cromwell, Thomas G. DeLoughery, Robert E. Fleming, Martina Fraga, George Goshua, Paula D. James, Adam K Lewkowitz, Jori Ellen May, Grace Nnadozie, Frances Ogunnaya, Guillermo J. Ruiz-Arguelles, Michelle Sholzberg, Layla Van Doren, Angela C. Weyand, Michelle Paula Zeller, Muayad Azzam, Ali Choaib, Qais Hamarsha, Hassan Kawtharany, Jana Khawandi, Reem A. Mustafa
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe
-
Nov 4, 2026, 13:38Fiona Robinson: NBDF Webinar Explores the Practical Challenges of Hemophilia Gene Therapy